Prada, P. O., Hirabara, S. M., de Souza, C. T., Schenka, A. A., Zecchin, H. G., Vassallo, J., Velloso, L. A., Carneiro, E., Carvalheira, J. B., Curi, R., and Saad, M. J. L-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity. Diabetologia 2007;50(9):1949-1959. [RETRACTED]. View abstract.
Pytlik, R., Benes, P., Patorkova, M., Chocenska, E., Gregora, E., Prochazka, B., and Kozak, T. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant. 2002;30(12):953-961. View abstract.
Pytlik, R., Gregora, E., Benes, P., and Kozak, T. [Effect of parenteral glutamine on restoration of lymphocyte subpopulations after high-dose chemotherapy and autologous hematopoietic cell transplantation: data from a double-blind randomized study]. Epidemiol.Mikrobiol.Imunol. 2002;51(4):152-155. View abstract.
Quan, Z. F., Yang, C., Li, N., and Li, J. S. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J.Gastroenterol. 7-1-2004;10(13):1992-1994. View abstract.
Rogeri, P. S. and Costa Rosa, L. F. Plasma glutamine concentration in spinal cord injured patients. Life Sci 9-23-2005;77(19):2351-2360. View abstract.
Sax, H. C. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. JPEN J.Parenter.Enteral Nutr. 1992;16(6):589-590. View abstract.
Scheid, C., Hermann, K., Kremer, G., Holsing, A., Heck, G., Fuchs, M., Waldschmidt, D., Herrmann, H. J., Sohngen, D., Diehl, V., and Schwenk, A. Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy. Nutrition 2004;20(3):249-254. View abstract.
Scheltinga, M. R., Young, L. S., Benfell, K., Bye, R. L., Ziegler, T. R., Santos, A. A., Antin, J. H., Schloerb, P. R., and Wilmore, D. W. Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress. Ann.Surg. 1991;214(4):385-393. View abstract.
Schloerb, P. R. and Amare, M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J.Parenter.Enteral Nutr. 1993;17(5):407-413. View abstract.
Schulman, A. S., Willcutts, K. F., Claridge, J. A., Evans, H. L., Radigan, A. E., O'Donnell, K. B., Camden, J. R., Chong, T. W., McElearney, S. T., Smith, R. L., Gazoni, L. M., Farinholt, H. M., Heuser, C. C., Lowson, S. M., Schirmer, B. D., Young, J. S., and Sawyer, R. G. Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med 2005;33(11):2501-2506. View abstract.
Schulman, A. S., Willcutts, K. F., Claridge, J. A., O'Donnell, K. B., Radigan, A. E., Evans, H. L., McElearney, S. T., Hedrick, T. L., Lowson, S. M., Schirmer, B. D., Young, J. S., and Sawyer, R. G. Does enteral glutamine supplementation decrease infectious morbidity? Surg.Infect.(Larchmt.) 2006;7(1):29-35. View abstract.
Sheridan, R. L., Prelack, K., Yu, Y. M., Lydon, M., Petras, L., Young, V. R., and Tompkins, R. G. Short-term enteral glutamine does not enhance protein accretion in burned children: a stable isotope study. Surgery 2004;135(6):671-678. View abstract.
Spittler, A., Sautner, T., Gornikiewicz, A., Manhart, N., Oehler, R., Bergmann, M., Fugger, R., and Roth, E. Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes. Clin.Nutr. 2001;20(1):37-42. View abstract.
Stehle, P., Zander, J., Mertes, N., Albers, S., Puchstein, C., Lawin, P., and Furst, P. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 2-4-1989;1(8632):231-233. View abstract.
Stubblefield, M. D., Vahdat, L. T., Balmaceda, C. M., Troxel, A. B., Hesdorffer, C. S., and Gooch, C. L. Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study. Clin.Oncol.(R.Coll.Radiol.) 2005;17(4):271-276. View abstract.
Sykorova, A., Horacek, J., Zak, P., Kmonicek, M., Bukac, J., and Maly, J. A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies -- three years' follow-up. Neoplasma 2005;52(6):476-482. View abstract.
Thompson, S. W., McClure, B. G., and Tubman, T. R. A randomized, controlled trial of parenteral glutamine in ill, very low birth-weight neonates. J.Pediatr.Gastroenterol.Nutr. 2003;37(5):550-553. View abstract.
Tjader, I., Rooyackers, O., Forsberg, A. M., Vesali, R. F., Garlick, P. J., and Wernerman, J. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med. 2004;30(2):266-275. View abstract.
van den Berg, A., van Elburg, R. M., Twisk, J. W., and Fetter, W. P. Glutamine-enriched enteral nutrition in very low birth weight infants. Design of a double-blind randomised controlled trial [ISRCTN73254583]. BMC.Pediatr. 9-1-2004;4:17. View abstract.
van den Berg, A., van Elburg, R. M., Westerbeek, E. A., Twisk, J. W., and Fetter, W. P. Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial. Am.J Clin.Nutr. 2005;81(6):1397-1404. View abstract.
van Hall, G., Saris, W. H., van de Schoor, P. A., and Wagenmakers, A. J. The effect of free glutamine and peptide ingestion on the rate of muscle glycogen resynthesis in man. Int.J.Sports Med. 2000;21(1):25-30. View abstract.
van Loon, F. P., Banik, A. K., Nath, S. K., Patra, F. C., Wahed, M. A., Darmaun, D., Desjeux, J. F., and Mahalanabis, D. The effect of L-glutamine on salt and water absorption: a jejunal perfusion study in cholera in humans. Eur.J.Gastroenterol.Hepatol. 1996;8(5):443-448. View abstract.
Vaughn, P., Thomas, P., Clark, R., and Neu, J. Enteral glutamine supplementation and morbidity in low birth weight infants. J.Pediatr. 2003;142(6):662-668. View abstract.
Velasco, N., Hernandez, G., Wainstein, C., Castillo, L., Maiz, A., Lopez, F., Guzman, S., Bugedo, G., Acosta, A. M., and Bruhn, A. Influence of polymeric enteral nutrition supplemented with different doses of glutamine on gut permeability in critically ill patients. Nutrition 2001;17(11-12):907-911. View abstract.
Vicario, M., Amat, C., Rivero, M., Moreto, M., and Pelegri, C. Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis. J Nutr. 2007;137(8):1931-1937. View abstract.
Walsh, N. P., Blannin, A. K., Bishop, N. C., Robson, P. J., and Gleeson, M. Effect of oral glutamine supplementation on human neutrophil lipopolysaccharide-stimulated degranulation following prolonged exercise. Int.J.Sport Nutr.Exerc.Metab 2000;10(1):39-50. View abstract.
Williams, J. Z., Abumrad, N., and Barbul, A. Effect of a specialized amino acid mixture on human collagen deposition. Ann.Surg. 2002;236(3):369-374. View abstract.
Williams, R., Olivi, S., Li, C. S., Storm, M., Cremer, L., Mackert, P., and Wang, W. Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia. J.Pediatr.Hematol.Oncol. 2004;26(10):619-625. View abstract.
Wischmeyer, P. E., Lynch, J., Liedel, J., Wolfson, R., Riehm, J., Gottlieb, L., and Kahana, M. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001;29(11):2075-2080. View abstract.
Wischmeyer, P., Pemberton, J. H., and Phillips, S. F. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin.Proc. 1993;68(10):978-981. View abstract.
Yalcin, S. S., Yurdakok, K., Tezcan, I., and Oner, L. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea. J.Pediatr.Gastroenterol.Nutr. 2004;38(5):494-501. View abstract.
Bouslama, L., Hayashi, K., Lee, J. B., Ghorbel, A., and Hayashi, T. Potent virucidal effect of pheophorbide a and pyropheophorbide a on enveloped viruses. J.Nat.Med. 2011;65(1):229-233. View abstract.
Budinsky, A., Wolfram, R., Oguogho, A., Efthimiou, Y., Stamatopoulos, Y., and Sinzinger, H. Regular ingestion of opuntia robusta lowers oxidation injury. Prostaglandins Leukot.Essent.Fatty Acids 2001;65(1):45-50. View abstract.
de, Wit M., Nel, P., Osthoff, G., and Labuschagne, M. T. The effect of variety and location on cactus pear (Opuntia ficus-indica) fruit quality. Plant Foods Hum.Nutr. 2010;65(2):136-145. View abstract.
Ennouri, M., Fetoui, H., Bourret, E., Zeghal, N., and Attia, H. Evaluation of some biological parameters of Opuntia ficus indica. 1. Influence of a seed oil supplemented diet on rats. Bioresour.Technol. 2006;97(12):1382-1386. View abstract.
Ennouri, M., Fetoui, H., Bourret, E., Zeghal, N., Guermazi, F., and Attia, H. Evaluation of some biological parameters of Opuntia ficus indica. 2. Influence of seed supplemented diet on rats. Bioresour.Technol. 2006;97(16):2136-2140. View abstract.
Fernandez, M. L., Lin, E. C., Trejo, A., and McNamara, D. J. Prickly pear (Opuntia sp.) pectin reverses low density lipoprotein receptor suppression induced by a hypercholesterolemic diet in guinea pigs. J Nutr 1992;122(12):2330-2340. View abstract.
Fernandez, M. L., Trejo, A., and McNamara, D. J. Pectin isolated from prickly pear (Opuntia sp.) modifies low density lipoprotein metabolism in cholesterol-fed guinea pigs. J Nutr 1990;120(11):1283-1290. View abstract.
Frati AC, Jimenex E Aruza R. Hypoglycemic effect of Opuntia ficus indica in non-insulin dependent diabetes mellitus patients. Phytother Res 1990;4(5):195-197.
Frati, A. C., Gordillo, B. E., Altamirano, P., Ariza, C. R., Cortes-Franco, R., Chavez-Negrete, A., and Islas-Andrade, S. Influence of nopal intake upon fasting glycemia in type II diabetics and healthy subjects. Arch Invest Med (Mex.) 1991;22(1):51-56. View abstract.
Frati-Munari, A. C., de Leon, C., Ariza-Andraca, R., Banales-Ham, M. B., Lopez-Ledesma, R., and Lozoya, X. [Effect of a dehydrated extract of nopal (Opuntia ficus indica Mill.) on blood glucose]. Arch.Invest Med.(Mex.) 1989;20(3):211-216. View abstract.
Frati-Munari, A. C., Fernandez-Harp, J. A., Banales-Ham, M., and Ariza-Andraca, C. R. Decreased blood glucose and insulin by nopal (Opuntia sp.). Arch Invest Med (Mex.) 1983;14(3):269-274. View abstract.
Frati-Munari, A. C., Fernandez-Harp, J. A., de la, Riva H., Ariza-Andraca, R., and del Carmen, Torres M. Effects of nopal (Opuntia sp.) on serum lipids, glycemia and body weight. Arch Invest Med (Mex.) 1983;14(2):117-125. View abstract.
Frati-Munari, A. C., Rios, Gil U., Ariza-Andraca, C. R., Islas, Andrade S., and Lopez, Ledesma R. [Duration of the hypoglycemic action of Opuntia streptacantha Lem.]. Arch Invest Med (Mex.) 1989;20(4):297-300. View abstract.
Galati, E. M., Mondello, M. R., Lauriano, E. R., Taviano, M. F., Galluzzo, M., and Miceli, N. Opuntia ficus indica (L.) Mill. fruit juice protects liver from carbon tetrachloride-induced injury. Phytother Res 2005;19(9):796-800. View abstract.
Godard, M. P., Ewing, B. A., Pischel, I., Ziegler, A., Benedek, B., and Feistel, B. Acute blood glucose lowering effects and long-term safety of OpunDia supplementation in pre-diabetic males and females. J.Ethnopharmacol. 8-9-2010;130(3):631-634. View abstract.
Kleiner, O., Cohen, Z., and Mares, A. J. Low colonic obstruction due to Opuntia ficus indica seeds: the aftermath of enjoying delicious cactus fruits. Acta Paediatr. 2002;91(5):606-607. View abstract.
Laurenz, J. C., Collier, C. C., and Kuti, J. O. Hypoglycaemic effect of Opuntia lindheimeri Englem in a diabetic pig model. Phytother Res 2003;17(1):26-29. View abstract.
Li, C. Y., Cheng, X. S., Cui, M. Z., and Yan, Y. G. [Regulative effect of Opuntia powder on blood lipids in rats and its mechanism]. Zhongguo Zhong.Yao Za Zhi. 2005;30(9):694-696. View abstract.
Lim, K. T. Inhibitory effect of glycoprotein isolated from Opuntia ficus-indica var. saboten MAKINO on activities of allergy-mediators in compound 48/80-stimulated mast cells. Cell Immunol. 2010;264(1):78-85. View abstract.
Linares, E., Thimonier, C., and Degre, M. The effect of NeOpuntia on blood lipid parameters--risk factors for the metabolic syndrome (syndrome X). Adv.Ther. 2007;24(5):1115-1125. View abstract.
Meckes-Lozyoa, M. and Roman-Ramos, R. Opuntia streptacantha: a coadjutor in the treatment of diabetes mellitus. Am J Chin Med 1986;14(3-4):116-118. View abstract.
Palumbo, B., Efthimiou, Y., Stamatopoulos, J., Oguogho, A., Budinsky, A., Palumbo, R., and Sinzinger, H. Prickly pear induces upregulation of liver LDL binding in familial heterozygous hypercholesterolemia. Nucl.Med Rev Cent.East Eur 2003;6(1):35-39. View abstract.
Pittler, M. H., Verster, J. C., and Ernst, E. Interventions for preventing or treating alcohol hangover: systematic review of randomised controlled trials. BMJ 12-24-2005;331(7531):1515-1518. View abstract.
Sanchez, E., Garcia, S., and Heredia, N. Extracts of edible and medicinal plants damage membranes of Vibrio cholerae. Appl.Environ.Microbiol. 2010;76(20):6888-6894. View abstract.
Steinberg, J. M. and Eitan, A. Prickly pear fruit bezoar presenting as rectal perforation in an elderly patient. Int J Colorectal Dis. 2003;18(4):365-367. View abstract.
Tesoriere L, Allegra M Butera D et al. Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: Potential health effects of betalains in humans. Am J Clin Nutr 2004;80:941-945.
Wolfram, R. M., Kritz, H., Efthimiou, Y., Stomatopoulos, J., and Sinzinger, H. Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hyperlipidemia--a pilot study. Wien.Klin.Wochenschr. 10-31-2002;114(19-20):840-846. View abstract.
Ahmad A, Davies J, Randall S, Skinner GR. Antiviral properties of extract of Opuntia streptacantha. Antiviral Res 1996;30:75-85. View abstract.
Akacha A, Rebai T, Zourgui L, Amri M. Preventive effect of ethanolic extract of cactus (Opuntia ficus-indica) cladodes on methotrexate-induced oxidative damage of the small intestine in Wistar rats. J Cancer Res Ther. 2018;14(Supplement):S779-84. doi: 10.4103/0973-1482.174555. View abstract.
Argaez-Lopez N, Wacher NH, Kumate-Rodriguez J, et al. The use of complementary and alternative medicine therapies in type 2 diabetic patients in Mexico. Diabetes Care 2003;26:2470-1. View abstract.
Bacardi-Gascon M, Duenas-Mena D, Jimenez-Cruz A. Lowering effect on postprandial glycemic response of nopales added to Mexican breakfasts. Diabetes Care 2007;30:1264-5. View abstract.
Bush TM, Rayburn KS, Holloway SW, et al. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Altern Ther Health Med 2007;13:30-5. View abstract.
Cárdenas Y, Ríos-Silva M, Huerta M, et al. The comparative effect of nopal and mucilage in metabolic parameters in rats with a high-fructose diet. J Med Food 2019;22(5):538-41. doi: 10.1089/jmf.2018.0124. View abstract.
De Santiago E, Gill CIR, Carafa I, Tuohy KM, De Peña MP, Cid C. Digestion and colonic fermentation of raw and cooked Opuntia ficus-indica cladodes impacts bioaccessibility and bioactivity. J Agric Food Chem 2019;67(9):2490-9. doi: 10.1021/acs.jafc.8b06480. View abstract.
Fernandez ML, Lin EC, Trejo A, McNamara DJ. Prickly pear (Opuntia sp.) pectin alters hepatic cholesterol metabolism without affecting cholesterol absorption in guinea pigs fed a hypercholesterolemic diet. J Nutr 1994;124:817-24. View abstract.
Frati AC, Xilotl Diaz N, Altamirano P, et al. The effect of two sequential doses of Opuntia streptacantha upon glycemia. Arch Invest Med (Mex) 1991;22:333-6. View abstract.
Frati Munari AC, Quiroz Lazaro JL, Alramirano Bustamante P, et al. The effect of various doses of nopal (Opuntia streptacantha Lemaire) on the glucose tolerance test in healthy individuals. Arch Invest Med (Mex) 1988;19:143-8.
Frati Munari AC, Vera Lastra O, Ariza Andraca CR. Evaluation of nopol capsules in diabetes mellitus. Gac Med Mex 1992;128:431-6. View abstract.
Frati-Munari AC, Altamirano-Bustamante E, Rodríguez-Bárcenas N, et al. Hypoglycemic action of Opuntia streptacantha Lemaire: study using raw extracts. Arch Invest Med (Mex) 1989;20:321-5. View abstract.
Frati-Munari AC, Del Valle-Martinez LM, Ariza-Andraca CR, et al. Hypoglycemic action of different doses of nopal (Opuntia streptacantha Lemaire) in patients with type II diabetes mellitus. Arch Invest Med (Mex) 1989;20:197-201. View abstract.
Frati-Munari AC, Gordillo BE, Altamirano P, Ariza CR. Hypoglycemic effect of Opuntia streptacantha Lemaire in NIDDM. Diabetes Care 1988;11:63-6. View abstract.
Frati-Munari AC, Licona-Quesada R, Araiza-Andraca CR, et al. Activity of Opuntia streptocantha in healthy individuals with induced hyperglycemia. Arch Invest Med (Mex) 1990;21:99-102. View abstract.
Frati-Munari AC, Roca-Vides RA, Lopez-Perez RJ, et al. The glycemic index of some foods common in Mexico. Gac Med Mex 1991;127:163-70. View abstract.
Gambino G, Brighina F, Allegra M, et al. Modulation of Human Motor Cortical Excitability and Plasticity by Opuntia Ficus Indica Fruit Consumption: Evidence from a Preliminary Study through Non-Invasive Brain Stimulation. Nutrients 2022;14(22):4915. View abstract.
Giglio RV, Carruba G, Cicero AFG, et al. Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study. Metabolites 2020;10(11):428. View abstract.
Han EH, Lim MK, Lee S, et al. Efficacy of Ethanolic Extract of Opuntia ficus-indica var. saboten Stems for Improving Cognitive Function in Elderly Subjects 55-85 Years of Age: A Randomized, Double-Blind, Placebo-Controlled Study. J Med Food 2020;23(11):1146-1154. View abstract.
Jeong H, Kim S, Kim MY, et al. Inhibitory and inductive effects of Opuntia ficus indica extract and its flavonoid constituents on cytochrome P450s and UDP-glucuronosyltransferases. Int J Mol Sci 2018;19(11):3400. doi: 10.3390/ijms19113400. View abstract.
López-Romero P, Pichardo-Ontiveros E, Avila-Nava A, Vázquez-Manjarrez N, Tovar AR, Pedraza-Chaverri J, et al. The effect of Nopal (Opuntia Ficus Indica) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts. J Acad Nutr Diet. 2014;114(11):1811-8. View abstract.
Malfa GA, Di Giacomo C, Cardia L, Sorbara EE, Mannucci C, Calapai G. A standardized extract of Opuntia ficus-indica (L.) Mill and Olea europaea L. improves gastrointestinal discomfort: A double-blinded randomized-controlled study. Phytother Res 2021;35(7):3756-3768. View abstract.
Meckes-Lozyoa M, Roman-Ramos R. Opuntia streptacantha; a coadjutor in the treatment of diabetes mellitus. Am J Chin Med 1986;14:116-8.
Newcomer AD, Park HS, O'Brien PC, McGill DB. Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. Am J Clin Nutr 1983;38:257-63. View abstract.
Onakpoya IJ, O'Sullivan J, Heneghan CJ. The effect of cactus pear (Opuntia ficus-indica) on body weight and cardiovascular risk factors: a systematic review and meta-analysis of randomized clinical trials. Nutrition. 2015;31(5):640-6. View abstract.
Palevitch D, Earon G, Levin I. Treatment of benign prostatic hypertrophy with Opuntia ficus-indica (L.) Miller. Int J Comp Alt Med 1994;Sept:21-2.
Preen D, Dawson B, Goodman C, et al. Effect of creatine loading on long-term sprint exercise performance and metabolism. Med Sci Sports Exerc 2001;33:814-21. View abstract.
Rayburn K, Martinez R, Escobedo M, et al. Glycemic effects of various species of nopal (Opuntia sp.) in type 2 diabetes mellitus. Texas J Rural Health 1998;26:68-76.
Roman-Ramos R, Flores-Saenz JL, Alarcon-Aguilar FJ. Anti-hyperglycemic effect of some edible plants. J Ethnopharmacol 1995;48:25-32. View abstract.
Roman-Ramos R, Flores-Saenz JL, Partida-Hernandez G, et al. Experimental study of the hypoglycemic effect of some antidiabetic plants. Arch Invest Med (Mex) 1991;22:87-93. View abstract.
Sobieraj DM, Freyer CW. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus. Ann Pharmacother 2010;44:1334-7. View abstract.
Tesoriere L, Butera D, Pintaudi AM, et al. Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases oxidative stress in healthy humans: a comparative study with vitamin C. Am J Clin Nutr 2004;80:391-5. View abstract.
Trejo-Gonzalez A, Gabriel-Ortiz G, Puebla-Perez A, et al. A purified extract from prickly pear cactus (Opuntia fuliginosa) controls experimentally induced diabetes in rats. J Ethnopharmacol 1996;55:27-33. View abstract.
Wiese J, McPherson S, Odden MC, Shlipak MG. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med 2004;164:1334-40. View abstract.
Wolfram R, Budinsky A, Efthimiou Y, et al. Daily prickly pear consumption improves platelet function. Prostaglandins Leukot Essent Fatty Acids 2003;69:61-6. View abstract.
You Might Also Like
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.